Genetic clues to muscle wasting in pancreatic cancer under investigation

NCT ID NCT05376592

Recruiting now Knowledge-focused Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jan 23, 2026 · Last updated Apr 28, 2026 · Updated 13 times

Summary

This study explores why many pancreatic cancer patients develop severe muscle wasting, known as cachexia. Researchers will collect blood samples from 100 patients to look for genetic differences that may be linked to this condition. The goal is to better understand the causes and eventually help develop new ways to diagnose or treat cachexia.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CACHEXIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Atrium Health Wake Forest Baptist Comprehensive Cancer Center
RECRUITING

Winston-Salem, North Carolina, 27103, United States

Contact Email: •••••@•••••
Levine Cancer Institute
RECRUITING

Charlotte, North Carolina, 28204, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

CACHEXIA PANCREAS ADENOCARCINOMA PANCREAS ADENOCARCINOMA